The Liebowitz Social Anxiety Scale: A comparison of the psychometric properties of self-report and clinician-administered formats

Psychological Medicine

Volumn 31, Issue 6, 2001, Pages 1025-1035

  Fresco, D M ^a,b,c,d   Coles, M E ^a,b,c,d   Heimberg, R G ^a,b,c,d   Liebowitz, M R ^a,b,c,d   Hami, S ^a,b,c,d   Stein, M B ^a,b,c,d   Goetz, D ^a,b,c,d  

^a TEMPLE UNIVERSITY   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY NEUROSIS; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PHYSICIAN; PSYCHOLOGIC ASSESSMENT; PSYCHOMETRY; RATING SCALE; SCORING SYSTEM; SELF REPORT; TIME; VALIDATION PROCESS;

ADULT; ANXIETY DISORDERS; DEPRESSION; FEMALE; HUMANS; MALE; PHOBIC DISORDERS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUESTIONNAIRES; RANDOM ALLOCATION; REPRODUCIBILITY OF RESULTS; SELF ASSESSMENT (PSYCHOLOGY);

EID: 0034910886     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0033291701004056     Document Type: Article

References (35)

1. Paroxetine in social phobia/social anxiety disorder: Randomized, double-blind, placebo-controlled study
2. Cognitive Therapy of Depression
3. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
4. Measures of depressive dimensions: Are they interchangeable?
5. Validation of the Social Interaction Anxiety Scale and the Social Phobia Scale across the anxiety disorders
6. Validation of the Beck Depression Inventory in a university population using psychiatric estimate as the criterion
7. Coefficient alpha and the internal structure of tests
8. A psychometric evaluation of the Beck Depression Inventory in adults with social anxiety disorder
9. A comparison of social phobia outcome measures in cognitive-behavioral group therapy
10. Anxiety Disorders Interview Schedule for DSM-IV: Lifetime Version(ADIS-IV-L)
11. Structured Clinical Interview for Axis I DSM-IV Disorders-Patient Version (SCID-I/P, Version 2.0)
12. A rating scale for depression
13. Cognitive-behavioral group therapy versus phenelzine in social phobia: 12-week outcome
14. Assessment of anxiety in social interaction and being observed by others: The Social Interaction Anxiety Scale and the Social Phobia Scale
15. Cognitive behavioral group treatment for social phobia: Description, case presentation, and empirical support
16. Psychometric properties of the Liebowitz Social Anxiety Scale
17. Computer-assisted rating scales for social phobia: Reliability and validity may not be what they appear
18. Issues and recommendations regarding use of the Beck Depression Inventory
19. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States, results from the National Comorbidity Survey
20. Lifetime comorbidities between social phobia and mood disorders in the US National Comorbidity Survey
21. Computer-administered rating scales for social anxiety in a clinical drug trial
22. Social phobia
23. Social phobia: Review of a neglected anxiety disorder
24. Brofaromine for social phobia: A multicenter, placebo-controlled, double-blind study
25. Brief standard self-rating for phobic patients
26. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety
27. Moclobemide in social phobia: A controlled dose-response trial
28. Validity and clinical utility of the Fear Questionnaire for anxiety-disordered patients
29. Quality of life in social phobia
30. Social phobia: Comorbidity and morbidity in an epidemiologic sample
31. Functional impairment in social phobia
32. Social Phobia: Clinical and Research Perspectives
33. Paroxetine treatment of generalized social phobia (social anxiety disorder): A randomized controlled trial
34. Social phobia in the primary care medical setting